MYNZ
Income statement / Annual
Last year (2023), Mainz Biomed B.V.'s total revenue was $895,479.00,
an increase of 69.00% from the previous year.
In 2023, Mainz Biomed B.V.'s net income was -$26.30 M.
See Mainz Biomed B.V.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$895,479.00
|
$529,877.00
|
$577,348.00
|
$493,565.00
|
$281,393.00
|
| Cost of Revenue |
$385,820.00 |
$347,726.00 |
$399,726.00 |
$370,480.00 |
$342,664.00 |
| Gross Profit |
$509,659.00 |
$182,151.00 |
$177,622.00 |
$123,085.00 |
-$61,271.00 |
| Gross Profit Ratio |
0.57 |
0.34 |
0.31 |
0.25 |
-0.22 |
| Research and Development
Expenses |
$9.59 M
|
$3.66 M
|
$466,689.00
|
$311,851.00
|
$250,316.00
|
| General & Administrative
Expenses |
$13.42 M
|
$17.83 M
|
$8.45 M
|
$347,994.00
|
$388,785.00
|
| Selling & Marketing
Expenses |
$3.80 M
|
$4.98 M
|
$957,522.00
|
$110,380.00
|
$181,460.00
|
| Selling, General &
Administrative Expenses |
$17.22 M
|
$22.81 M
|
$9.41 M
|
$458,374.00
|
$570,245.00
|
| Other Expenses |
$342,403.00 |
-$114,048.00 |
-$320,892.00 |
-$290,839.00 |
-$130,349.00 |
| Operating Expenses |
$27.15 M |
$26.36 M |
$9.56 M |
$479,386.00 |
$690,212.00 |
| Cost And Expenses |
$27.54 M |
$26.70 M |
$9.96 M |
$849,866.00 |
$1.03 M |
| Interest Income |
$0.00 |
$289,324.00 |
$339,171.00 |
$268,792.00 |
$201,936.00 |
| Interest Expense |
$809,581.00 |
$289,324.00 |
$339,171.00 |
$268,792.00 |
$201,936.00 |
| Depreciation &
Amortization |
$1.03 M
|
$459,426.00
|
$209,903.00
|
$152,837.00
|
$53,042.00
|
| EBITDA |
-$25.01 M
|
-$25.72 M
|
-$11.28 M
|
-$257,641.00
|
-$702,077.00
|
| EBITDA Ratio |
-27.93 |
-48.41 |
-16.05 |
-0.54 |
-2.43 |
| Operating Income Ratio
|
-29.75
|
-49.4
|
-16.25
|
-0.66
|
-3.28
|
| Total Other
Income/Expenses Net |
$348,955.00
|
$56,704.00
|
-$1.97 M
|
-$261,084.00
|
-$35,146.00
|
| Income Before Tax |
-$26.30 M |
-$26.39 M |
-$11.70 M |
-$586,895.00 |
-$957,055.00 |
| Income Before Tax Ratio
|
-29.36
|
-49.8
|
-20.26
|
-1.19
|
-3.4
|
| Income Tax Expense |
$0.00 |
$65,389.00 |
$377,122.00 |
$299,282.00 |
$217,711.00 |
| Net Income |
-$26.30 M |
-$26.45 M |
-$12.07 M |
-$886,177.00 |
-$1.17 M |
| Net Income Ratio |
-29.36 |
-49.92 |
-20.91 |
-1.8 |
-4.17 |
| EPS |
-1.62 |
-1.87 |
-1.67 |
-0.16 |
-0.1 |
| EPS Diluted |
-1.62 |
-1.87 |
-1.67 |
-0.16 |
-0.1 |
| Weighted Average Shares
Out |
$16.24 M
|
$14.16 M
|
$7.21 M
|
$5.61 M
|
$11.71 M
|
| Weighted Average Shares
Out Diluted |
$16.24 M
|
$14.16 M
|
$7.21 M
|
$5.61 M
|
$11.71 M
|
| Link |
|
|
|
|
|
